Bioage Labs Inc (BIOA)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Bioage Labs Inc Stock (BIOA) Company Profile

Bioage Labs Inc

Healthcare (1155)

510-806-1445

1445A SOUTH 50TH STREET, RICHMOND

Nächster Verdiensttermin

Neueste SEC-Einreichungen

BIOA's Discussions on Twitter

Vergleichen Sie BIOA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BIOA Bioage Labs Inc	4.3562	144.12M	0	0	0	0.00
ZTS Zoetis Inc	152.72	65.50B	9.26B	2.49B	2.30B	5.47
TAK Takeda Pharmaceutical Co Adr	15.16	46.99B	30.25B	1.37B	5.08B	0.4257
HLN Haleon Plc Adr	10.21	45.96B	14.35B	1.85B	0	0.4023
TEVA Teva Pharmaceutical Industries Ltd Adr	14.88	17.04B	16.54B	-1.64B	749.00M	-1.45
UTHR United Therapeutics Corp	294.44	12.77B	2.76B	1.11B	898.10M	22.77

Bioage Labs Inc Stock (BIOA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-02-28	Eingeleitet	William Blair	Mkt Perform
2024-12-10	Herabstufung	Morgan Stanley	Overweight → Underweight
2024-12-09	Herabstufung	Citigroup	Buy → Neutral
2024-12-09	Herabstufung	Jefferies	Buy → Hold
2024-10-21	Eingeleitet	Citigroup	Buy
2024-10-21	Eingeleitet	Jefferies	Buy
2024-10-21	Eingeleitet	Morgan Stanley	Overweight

Alle ansehen

Bioage Labs Inc Aktie (BIOA) Neueste Nachrichten

Finanzdaten der Bioage Labs Inc-Aktie (BIOA)

Es liegen keine Finanzdaten für Bioage Labs Inc (BIOA) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Bioage Labs Inc (BIOA)

Bioage Labs Inc Stock (BIOA) Company Profile

Vergleichen Sie BIOA mit anderen Aktien

Bioage Labs Inc Stock (BIOA) Upgrades & Downgrades

Bioage Labs Inc Aktie (BIOA) Neueste Nachrichten

Press Release Distribution & PR Platform - ACCESS Newswire

Investors who hold shares of BioAge Labs, Inc. (NASDAQ: BIOA) - openPR.com

Notice to Long-Term Shareholders of BioAge Labs, Inc. - GlobeNewswire

Notice to Long-Term Shareholders of BioAge Labs, Inc. (NASDAQ: BIOA); Driven Bands Holdings - Bluefield Daily Telegraph

BioAge Labs, Inc. (BIOA): A Bull Case Theory - Insider Monkey

Grabar Law Office Investigates Claims on Behalf of - GlobeNewswire

Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of BioAge Labs, Inc. (NASDAQ: BIOA); NAPCO Security Technologies, Inc. (NASDAQ: NSSC); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Virtu Financial Inc. (NASDAQ: VI - TradingView

BIOA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that BioAge Labs, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

BioAge Labs (BIOA) Shares Plummet After Discontinuing Trial Just 2 Months After IPOHagens Berman - ACCESS Newswire

Several Insiders Invested In BioAge Labs Flagging Positive News - Yahoo Finance

Cautious Outlook on BioAge Labs Amid Promising Developments and High Risk - TipRanks

BioAge Labs, Inc.: Sell Rating Due to Discontinued Program and Uncertain Prospects - TipRanks

William Blair Sticks to Its Hold Rating for BioAge Labs, Inc. (BIOA) - The Globe and Mail

BioAge Labs Inc. (BIOA) reports earnings - Quartz

BioAge Labs, Inc. Advances NLRP3 Inhibitor BGE-102 and Forms Strategic Collaborations with Novartis and Lilly for Metabolic Diseases - Nasdaq

BioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the - Bluefield Daily Telegraph

BioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the Fourth Quarter of 2024 - TradingView

BioAge Labs Lands Massive $550M Novartis Deal Despite Clinical Setback in 2024 Results - Stock Titan

Final Deadline for the BioAge Labs, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsBIOA - The Malaysian Reserve

BIOA Deadline Today: BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit - PR Newswire

BIOA DEADLINE TODAY: ROSEN, LEADING INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors - Bluefield Daily Telegraph

BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire

Bioage Labs principal accounting officer Barton Shane buys $47,376 in common stock By Investing.com - Investing.com South Africa

Bioage Labs principal accounting officer Barton Shane buys $47,376 in common stock - Investing.com

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs - Markets Insider

Lost Money on BioAge Labs, Inc. (BIOA)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - GlobeNewswire

Lost Money on BioAge Labs, Inc. (BIOA)? Join Class Action Suit Seeking Recovery – Contact Levi ... - Bluefield Daily Telegraph

2025-03-10 | Shareholders that Lost Money on BioAge Labs, Inc. (BIOA) Should Contact Levi & Korsinsky About Pending Class ActionBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing

DEADLINE ALERT for REGN and BIOA: The Law Offices of Frank - GlobeNewswire

March 10, 2025 Filing Deadline in Securities Class ActionContact Kessler Topaz Meltzer & - FinancialContent

BIOA FINAL DEADLINE: BioAge Labs Investors are Encouraged - GlobeNewswire

Lost Money on BioAge Labs, Inc.(BIOA)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - ACCESS Newswire

BIOA Final Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm - themalaysianreserve.com

Investors in BioAge Labs, Inc. Should Contact The Gross Law Firm Before March 10, 2025 to Discuss Your RightsBIOA - GuruFocus.com

BioAge Labs, Inc. Class Action: The Gross Law Firm Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025BIOA - PR Newswire

Levi & Korsinsky Reminds BioAge Labs, Inc. Investors of the Pend - GuruFocus

2025-03-09 | Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 10, 2025 in BioAge Labs, Inc. LawsuitBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing

Class Action Filed Against BioAge Labs, Inc. (BIOA)March 10, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire

BioAge Labs, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before March 10, 2025 to Discuss Your RightsBIOA - ACCESS Newswire

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs - StreetInsider

BIOA Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. (BIOA) Investors of Filing Deadline in Class Action Lawsuit | StreetInsider.com - Financial Content

BIOA LEGAL NEWS: A Class Action was filed on behalf of BioAge Labs Investors - GlobeNewswire Inc.

BioAge Labs (BIOA) Abandons Obesity Drug Amid Shareholder Lawsuit – Hagens Berman - GlobeNewswire

Faruqi & Faruqi Reminds BioAge Investors of the Pending Class Act - The National Law Review

BIOA Deadline in 3 Days: Kessler Topaz Meltzer & Check, LLP - GlobeNewswire

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioAge ... - Bluefield Daily Telegraph

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioAge Labs, Inc. (BIOA) Shareholders - GlobeNewswire

BIOA DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors ... - The Bakersfield Californian

Deadline Soon: BioAge Labs, Inc. (BIOA) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - Business Wire

BIOA Deadline: Rosen Law Firm Urges BioAge Labs, Inc. (NASDAQ: BIOA) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - Joplin Globe

Cautious Outlook on BioAge Labs, Inc. Amid Program Discontinuation and Development Risks - TipRanks

Finanzdaten der Bioage Labs Inc-Aktie (BIOA)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie BIOA